Issue related to pharmaceutical compounding; Issues related to Domestic manufacturing;
2025 · 2nd Quarter (Apr 1 - June 30)
ENDO USA, INC., A MALLINCKRODT-ENDO COMPANY
Filed by JEFFREY J. KIMBELL & ASSOCIATES, INC..
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 14, 2025
- Income
- $20,000.00
- Expenses
- Not reported
- Registrant
- JEFFREY J. KIMBELL & ASSOCIATES, INC.
- Filing UUID
- 2d423093-de99-42bd-aeff-153a9acb51eb
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Implementation of the Inflation Reduction Act; Issues related to 340B
Issues related to pharmaceutical tariffs
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.